Premium
Good to great: TAVR tackles stroke risk
Author(s) -
Pelberg Justin,
Gray William A.
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26937
Subject(s) - medicine , valve replacement , randomized controlled trial , stroke (engine) , intensive care medicine , cardiology , surgery , mechanical engineering , stenosis , engineering
Key Points In this small feasibility trial of a next‐generation device, the TriGuardHDH embolic protection device (EPD) appears to be safe and feasible during use in the majority of the TAVR subjects studied. The question as to the use of EPD during TAVR, while intuitively appealing, is not further elucidated by the results of this small, uncontrolled study. Future research on this (and other) device(s) would be expected to include, at a minimum, a randomized arm, more standardized imaging, and neurological assessment (including longer‐term) protocols, and less variability in valve types used.